KCNIP1-OT1

Across TCGA pan-cancer cohorts, KCNIP1-OT1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of KCNIP1-OT1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where KCNIP1-OT1 RNA is repressed in tumor relative to normal tissue. In most cancer types KCNIP1-OT1 is over-expressed in tumor, although a few such as BLCA and COAD show the opposite, repressed pattern.

BLCA, COAD, and UCEC are the cancer types where KCNIP1-OT1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KCNIP1-OT1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	III,IV	−1.152	<.001	11	view →
COAD	All	II,III,IV	−0.269	<.001	8	view →
UCEC	All	All	−1.086	<.001	6	view →
BRCA	All	III,IV	−0.448	<.001	6	view →
LUSC	All	All	−0.051	<.001	5	view →
STAD	All	All	−0.378	.007	3	view →
READ	All	All	−0.506	.006	2	view →
PRAD	All	All	−0.427	<.001	2	view →
KICH	All	All	−0.041	.018	1	view →
KIRC	Male	All	+0.026	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

KCNIP1-OT1–BLCA

Open the BLCA breakdown →